ZAI LAB(09688.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at loss of USD 51.02 million, loss widened by 5.32% YoY

NewTimeSpace News, May 07, 2026, ZAI LAB(09688.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 99.61 million, decreased by 6.46% YoY; Net Profit stood at loss of USD 51.02 million, loss widened by 5.32% YoY; Profit Attributable to Shareholders stood at loss of USD 51.02 million, loss widened by 5.32% YoY; Basic Earnings Per Share (EPS) stood at loss of US cents 5.
In terms of profitability, ZAI LAB Gross Profit changed from USD 67.84 million in the same period last year to USD 61.28 million in the current period, decreased by USD 6.56 million; gross profit margin changed from 63.71% in the same period last year to 61.52% in the current period, decreased by 2.19 percentage points; net profit changed from loss of USD 48.44 million in the same period last year to loss of USD 51.02 million in the current period, decreased by USD 2.58 million; net profit margin changed from -45.49% in the same period last year to -51.22% in the current period, decreased by 5.73 percentage points.
In terms of earnings quality, ZAI LAB Operating Profit changed from loss of USD 56.31 million in the same period last year to loss of USD 69.39 million in the current period, decreased by USD 13.07 million; Operating Profit Margin changed from -52.88% in the same period last year to -69.66% in the current period, decreased by 16.78 percentage points.
In terms of financial soundness, ZAI LAB Debt-to-Asset Ratio changed from 30.9% in the same period last year to 39.59% in the current period, increased by 8.68 percentage points; Total Equity changed from USD 810.753 million in the same period last year to USD 661.981 million in the current period, decreased by USD 148.77 million; Current Liabilities changed from USD 319.81 million in the same period last year to USD 392.98 million in the current period, increased by USD 73.18 million; Quick Ratio changed from 3.09 in the same period last year to 2.19 in the current period, decreased by 0.9 percentage points.
In terms of R&D investment focus, ZAI LAB R&D Expenses changed from USD 60.73 million in the same period last year to USD 65.59 million in the current period, increased by USD 4.86 million; R&D to Total Revenue Ratio changed from 57.03% in the same period last year to 65.85% in the current period, increased by 8.82 percentage points.
By the close of trading on May 07, 2026, ZAI LAB(09688) saw a gain of 0.12% in its share price, closing at HKD 16.2. The full-day turnover stood at HKD 176.71 million, showing significant volume increase, with the latest market capitalization at HKD 18.37 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.